| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PATH | Common Stock | Options Exercise | $67,804 | +13,400 | $5.06 | 13,400 | 04 Nov 2021 | Direct | ||
| transaction | PATH | Common Stock | Sale | $759,536 | -13,400 | -100% | $56.68 | 0 | 04 Nov 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PATH | Stock Option (Right to Buy) | Options Exercise | $0 | -13,400 | -4.2% | $0.000000 | 306,818 | 04 Nov 2021 | Common Stock | 13,400 | $5.06 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | These shares were sold in compliance with a qualified selling plan adopted by the reporting person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. |
| F2 | The range of prices for the transactions reported were from $56.0900 to $57.2100. The reporting person will provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
| F3 | 25% of the shares underlying this stock option vested on April 15, 2020, with the remaining 75% vesting in 36 equal monthly installments. |